Health
Convalescent plasma is still in demand. But there are caveats – ABC News
This is a Kaiser Health News story.
Six months after it was controversially hailed by Trump administration officials as a breakthrough therapy to fight the worst effects of covid-19, convalescent plasma appears to be on the ropes.
The treatment that infuses blood plasma from recovered covid patients into people newly infected in hopes of boosting their immune response has not lived up to early hype. Some high-profile clinical trials have shown disappointing results. Demand from hospitals for the…
-
Noosa News23 hours agoMeasles alert issued across popular south-east attractions
-
General23 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
General17 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News7 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred